Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users

PloS One
Finn SigglekowLianne Parkin

Abstract

Maintaining adherence to statins reduces the risk of an initial cardiovascular disease (CVD) event in high-risk individuals (primary prevention) and additional CVD events following the first event (secondary prevention). The effectiveness of statin therapy is limited by the level of adherence maintained by the patient. We undertook a nationwide study to compare adherence and discontinuation in primary and secondary prevention patients. Dispensing data from New Zealand community pharmacies were used to identify patients who received their first statin dispensing between 2006 and 2011. The Medication Possession Ratio (MPR) and proportion who discontinued statin medication was calculated for the year following first statin dispensing for patients with a minimum of two dispensings. Adherence was defined as an MPR ≥ 0.8. Previous CVD was identified using hospital discharge records. Multivariable logistic regression was used to control for demographic and statin characteristics. Between 2006 and 2011 289,666 new statin users were identified with 238,855 (82.5%) receiving the statin for primary prevention compared to 50,811 (17.5%) who received it for secondary prevention. The secondary prevention group was 1.55 (95% CI 1.51-1.59) tim...Continue Reading

References

Jul 23, 2002·JAMA : the Journal of the American Medical Association·Cynthia A JackeviciusJack V Tu
Jun 24, 2004·Journal of General Internal Medicine·Jeffrey J EllisA Mark Fendrick
Apr 22, 2005·British Journal of Clinical Pharmacology·S PerreaultJ Collin
May 25, 2005·Archives of Internal Medicine·Richard H ChapmanJ Sanford Schwartz
Aug 5, 2005·The New England Journal of Medicine·Lars Osterberg, Terrence Blaschke
Jun 17, 2009·Circulation·P Michael HoJohn S Rumsfeld
Aug 22, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Alice DragomirSylvie Perreault
May 15, 2010·Journal of Epidemiology and Community Health·Santosh JatranaPauline Norris
Aug 13, 2010·The Annals of Pharmacotherapy·Devin M MannIan Kronish
Jan 5, 2011·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·I M CareyD G Cook
Mar 29, 2011·The American Journal of Cardiology·Donald G PittmanJoAnne M Foody
Apr 1, 2011·European Journal of Preventive Cardiology·Simon ThornleyRod Jackson
May 3, 2011·Journal of General Internal Medicine·Jerry L GrenardWalid F Gellad
Apr 11, 2012·British Journal of Clinical Pharmacology·Bernard VrijensUNKNOWN ABC Project Team
Jan 17, 2013·Current Medical Research and Opinion·Jonathan H WatanabeTimothy Chen
Jan 1, 2014·Journal of Managed Care Pharmacy : JMCP·Julia F SlejkoJonathan D Campbell
Feb 18, 2014·Journal of Clinical Lipidology·Emma J AarnioMaarit Jaana Korhonen
Oct 21, 2016·Circulation. Cardiovascular Quality and Outcomes·Emma AarnioMaarit J Korhonen
Jan 19, 2018·Journal of Cardiovascular Pharmacology and Therapeutics·Eva Martin-RuizDavid Epstein
Jan 24, 2018·BMJ Open·Rachelle Louise CutlerVictoria Garcia-Cardenas
Sep 1, 2016·Journal of Primary Health Care·Andrew J KerrGerry Devlin
Oct 30, 2019·International Journal for Equity in Health·Suetonia C PalmerSuzanne G Pitama
Jun 12, 2020·The Annals of Pharmacotherapy·Steven R EricksonJoshua Tootoo

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

PHARMS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved